Health In Tech financials
$0.8525−3.25%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 |
|---|---|---|
| Revenue | $33.3M | $19.5M |
| Gross profit | $20.9M | $15.4M |
| Gross margin | 62.8% | 79.2% |
| Operating income | $1.5M | $989.9K |
| Net income | $1.3M | $670.5K |
| Net margin | 3.8% | 3.4% |
| Diluted EPS | $0.02 | $0.01 |
| EBITDA | $2.4M | $1.5M |
| Operating cash flow | $3.1M | $2.2M |
| Free cash flow | $3.1M | $2.2M |
| Diluted shares | 57.7M | 53.7M |
Balance sheet
| Period end | Dec 31 | Dec 31 |
|---|---|---|
| Cash & equivalents | $7.7M | $7.8M |
| Short-term investments | $0.00 | $0.00 |
| Total debt | $0.00 | $0.00 |
| Total assets | $23.1M | $15.8M |
| Total liabilities | $6.0M | $2.6M |
| Shareholders' equity | $17.1M | $13.2M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology